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INTRODUCTION AND OBJECTIVES: Radical cystectomy (RC) for bladder cancer can significantly affect the sexual health and function of both male and female patients. The goal of our study was to characterize provider practice regarding sexual health counseling of RC patients and whether practice differs between male and female patients.
METHODS: We conducted a national survey of members of the Society of Urologic Oncology to assess topics included in pre-and postoperative sexual health counseling and identify barriers to counseling patients about sexual health. For each topic, we compared the frequency of counseling for male versus female patients using Chisquared tests.
RESULTS: A total of 136 of 723 members responded. Overall, the median age was 43 years (interquartile range [IQR] 38-51), 91.8% were male, 74.8% were in academic practice, 83.1% had completed a urologic oncology fellowship, and 86.2% trained residents. Average years in practice was 12.6AE11.1, 99% had previously performed a female RC, and 31.4% had performed at least 10 female RC's in the past year. Providers were significantly more likely to ask males if they were sexually active prior to RC compared to females (90.7% vs. 81.4%, respectively, p<0.001) (Figure 1 ). Comparing preoperative counseling of sexually active male and female patients, providers were significantly more likely to ask male patients if they had baseline sexual dysfunction (79.6% vs. 38.4%, respectively, p[0.002) , to discuss the risk of sexual dysfunction after RC with males (93.5% vs. 81.3%, respectively, p<0.001), and to discuss the potential for nerve-sparing RC with males (70.4% vs. 31.3%, respectively, p[0.001); postoperatively, providers were significantly more likely to discuss sexual health and dysfunction issues with sexually active males versus sexually active females (80% vs. 56%, respectively, p<0.001) (Figure 1) . When asked about barriers to discussing sexual health with females, 67.4% listed older patient age, 58.7% said there was not enough time, and 46.7% listed uncertainty about patients' baseline sexual function.
CONCLUSIONS: There were significant disparities in the sexual health counseling that women received pre-and post-RC compared to men. Since RC has a significant impact on female sexual health, it is critical to address barriers to counseling women about these issues. 
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INTRODUCTION AND OBJECTIVES:
In contrast to the large number of studies on erectile dysfunction after prostatectomy, research on orgasmic dysfunction has been limited. Painful orgasm is a form of ejaculatory dysfunction that can occur after prostatectomy. Although the incidence is not high, it can affect quality of life. Furthermore, the causes of and treatments for painful orgasm have not been clarified. In this study, we evaluated the efficacy of a selective alpha-blockade, tamsulosin, on post-prostatectomy painful orgasm. METHODS: We studied 90 patients with painful orgasm who underwent nerve sparing radical prostatectomy with prostate cancer. Patients were prescribed tamsulosin 0.2 mg daily for a total of 8 weeks. Primary outcomes were changes in scores for pain after treatment using a visual analog scale (VAS) and Global Assessment Questionnaire (GAQ) scores. We also identified the pain site and the reported time between ejaculation and onset of pain. We compared the results between groups of patients who underwent one of two surgical methods (laparoscopic vs. robot-assisted prostatectomy).
RESULTS: In all, 56 of 90 (62.2%) patients reported significant improvement in pain (!2 points on pain VAS) and 10 (11.1%) noted complete resolution of their pain. There was a statistically significant decrease in pain as measured by the VAS for both groups in response to tamsulosin treatment. The pain areas were penis (61.1%), testis (34.2%), perineum (33.3%), and lower abdomen (13.3%). Sixty-four (71.1%) patients reported pain within 3 min of orgasm. After treatment, the average VAS decreased by 2.8 points and there was a significant improvement in GAQ. However, we did not find any significant difference between the laparoscopic and robot-assisted prostatectomy groups.
CONCLUSIONS: We detected a statistically significant, beneficial effect of tamsulosin on postprostaomy patients with painful orgasms. Because ejaculatory function is a significant contributor to quality of life after prostatectomy, further studies should be performed on this topic.
